IMUX Next Earnings Date Notes

— Immunic, Inc. (IMUX) is a clinical-stage biopharmaceutical company focused on developing oral therapies for chronic inflammatory & autoimmune diseases, with a primary emphasis on conditions such as multiple sclerosis (MS), ulcerative colitis, & Crohn's disease. Its lead asset, vidofludimus calcium (IMU-838), is a selective immune modulator currently undergoing multiple late-stage clinical trials targeting relapsing & progressive forms of MS, as well as other inflammatory indications. For investors tuned into the earnings call, key business metrics to watch include updates on the progress & results of clinical trials—especially topline data readouts, timelines for trial completion, & regulatory milestones. Additionally, closely follow the company's cash position & burn rate, given Immunic's status as a pre-revenue biotech relying primarily on external funding or capital raises. Pipeline diversification, partnership announcements, & management's commentary on anticipated milestones represent further critical signals. Ultimately, Immunic's long-term success hinges on its ability to demonstrate compelling efficacy & safety data for its lead candidates, secure regulatory approvals, and maintain sufficient financial runway to reach those key developmental inflection points. The next projected earnings date for IMUX is 11/12/2026 6:00 am (stay tuned for a confirmed earnings date once announced).

IMUX Next Earnings Date FAQ

On this page we presented the IMUX Next Earnings Date information for Immunic along with recent past earnings dates. For Q2 of 2026, IMUX reported earnings of -0.800/share, with the earnings report taking place on 8/11/2026. For Q1 of 2026, IMUX reported earnings of -1.080/share, with the earnings report taking place on 5/13/2026. For Q4 of 2025, IMUX reported earnings of -0.700/share, with the earnings report taking place on 2/26/2026. For Q3 of 2025, IMUX reported earnings of -1.300/share, with the earnings report taking place on 11/13/2025. For Q2 of 2025, IMUX reported earnings of -2.000/share, with the earnings report taking place on 8/7/2025. Based on these past earnings dates, the projected next earnings date for IMUX is 11/12/2026 6:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Immunic. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Immunic shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Immunic next earnings dates as well as any other stock out there in our coverage universe, to see when the next IMUX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up IMUX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the IMUX next earnings date.